España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Ayurcann Hldgs
AYURF
OTCQB
Watchlist
Get Report
Perks
Buy
Compare Brokers
$0.049800
0
0.00%
Last update: 3:21 PM
15 minutes delayed
Get Report
Watch
Ayurcann Hldgs (AYURF) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Ayurcann Hldgs (OTC:AYURF) Stock
Ayurcann Hldgs Stock (OTC: AYURF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, June 28, 2024
Cannabis Extraction Company Ayurcann To Merge With Arogo, Resulting In $210M Entity
Nina Zdinjak
Tuesday, May 28, 2024
Marijuana Extraction Company Ayurcann Reports 127.7% YoY Revenue Growth For The Third Quarter
Nina Zdinjak
Tuesday, March 26, 2024
Canadian Cannabis Companies Could See Valuations Soar By Up To 300% With Tax Reform, New Report Shows
Nicolás Jose Rodriguez
Wednesday, February 28, 2024
Canadian Cannabis Extractor Ayurcann's Q2 Revenue Jumps Over 81% YoY, Net Loss Grows
Jelena Martinovic
Wednesday, November 29, 2023
Skyrocketing: This Canadian Cannabis Extractor Reports Record Earnings
Patricio Liddle
Tuesday, October 31, 2023
Defining Weed Industry Trends With Over 100% Revenue Boost In 2023: Cannabis Extractor's Latest Earnings
Jelena Martinovic
Monday, May 29, 2023
Canadian Cannabis Company Reports Mixed Results: Here's What's In Them
Maureen Meehan
Monday, February 27, 2023
Ayurcann Q2 FY23 Revenue Grows 4% YoY To $2.27M
Vuk Zdinjak
Tuesday, November 29, 2022
Ayurcann Q3 Revenue Grows 9.74% To $1.47M
Vuk Zdinjak
Monday, October 31, 2022
Ayurcann FY 2022 Net Revenue Grows 23%, What About Net Loss?
Vuk Zdinjak
Thursday, July 28, 2022
Ayurcann To Launch New Cannabis Products, Grants Restricted Share Units
Vuk Zdinjak
Wednesday, June 22, 2022
Ayurcann To Acquire Joints And Hustle & Shake Cannabis Brands For $5.5M In Stock
Vuk Zdinjak
Thursday, May 26, 2022
Ayurcann Slight Revenue Increase In Q3 Fiscal 2022 Of 7.69% YoY
Vuk Zdinjak
Tuesday, March 01, 2022
Cannabis Extraction Co. Ayurcann Holdings To Buyback Stock Under Normal Course Issuer Bid
Jelena Martinovic
Tuesday, February 22, 2022
Cannabis Extraction Co. Ayurcann Shares Slightly Up On Record Sales, 106% YoY Revenue Growth
Nina Zdinjak
Monday, January 31, 2022
Ayurcann Launches Fuego THC Vapes In Alberta And Symbol Change On OTCQB Market
Jelena Martinovic
